Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 5-androstene-16-fluoro-17-one
2. 5-androstene-16alpha-fluoro-17-one
3. Dhea Analog 8354
4. He2500
1. 112859-71-9
2. R7m5ugd04g
3. 156680-74-9
4. Chembl4441355
5. 16alpha-fluoro-5-androsten-17-one
6. (8r,9s,10r,13s,14s,16r)-16-fluoro-10,13-dimethyl-1,2,3,4,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-one
7. 16-fluoro-10,13-dimethyl-1,2,3,4,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-one
8. 16-fluoro-5-androsten-17-one
9. He2500
10. Unii-r7m5ugd04g
11. Ccris 4216
12. 8354 Compound
13. Schembl1418930
14. Niosh/bv8387230
15. Dtxsid90920920
16. Zinc3778181
17. Bdbm50507597
18. 16-alpha-fluoro-5-androsten-17-one
19. Db06250
20. Bv83872300
21. 16.alpha.-fluoroandrost-5-en-17-one
22. Androst-5-en-17-one, 16-fluoro-, (16alpha)-
23. Androst-5-en-17-one, 16-fluoro-, (16-alpha)-
24. J-002855
25. Androst-5-en-17-one, 16-fluoro-, (16.alpha.)-
26. Q27287895
27. (2r,3as,3br,9ar,9bs,11as)-2-fluoro-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9ah,9bh,10h,11h,11ah-cyclopenta[a]phenanthren-1-one
| Molecular Weight | 290.4 g/mol |
|---|---|
| Molecular Formula | C19H27FO |
| XLogP3 | 5.1 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 2 |
| Rotatable Bond Count | 0 |
| Exact Mass | 290.20459364 g/mol |
| Monoisotopic Mass | 290.20459364 g/mol |
| Topological Polar Surface Area | 17.1 Ų |
| Heavy Atom Count | 21 |
| Formal Charge | 0 |
| Complexity | 510 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 6 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Investigated for use/treatment in psoriasis and psoriatic disorders, hyperlipidemia, metabolic disease, cancer/tumors (unspecified), and obesity.
Fluasterone is a synthetically stable adrenocortical steroid fluorinated analogue of dehydroepiandrosterone (DHEA), a powerful anti-inflammatory molecule with androgenic or estrogenic side effects. It is proposed that fluasterone inhibits NF-kB activation and reduces oxidative stress, but other mechanisms may play a role. Fluasterone suppresses inflammation and is effective in preclinical models of chronic inflammatory disease including psoriasis, asthma, rheumatoid arthritis, multiple sclerosis and lupus erythematosus. Fluasterone has anti-inflammatory effects inpreclinical models of chronic inflammatory disease including psoriasis, asthma, rheumatoid arthritis, multiple sclerosis and lupus erythematosus. [Aeson Pharmaceuticals Executive Report]
ABOUT THIS PAGE
69
PharmaCompass offers a list of Fluasterone API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Fluasterone manufacturer or Fluasterone supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Fluasterone manufacturer or Fluasterone supplier.
PharmaCompass also assists you with knowing the Fluasterone API Price utilized in the formulation of products. Fluasterone API Price is not always fixed or binding as the Fluasterone Price is obtained through a variety of data sources. The Fluasterone Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Fluasterone manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Fluasterone, including repackagers and relabelers. The FDA regulates Fluasterone manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Fluasterone API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Fluasterone supplier is an individual or a company that provides Fluasterone active pharmaceutical ingredient (API) or Fluasterone finished formulations upon request. The Fluasterone suppliers may include Fluasterone API manufacturers, exporters, distributors and traders.
Fluasterone Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Fluasterone GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Fluasterone GMP manufacturer or Fluasterone GMP API supplier for your needs.
A Fluasterone CoA (Certificate of Analysis) is a formal document that attests to Fluasterone's compliance with Fluasterone specifications and serves as a tool for batch-level quality control.
Fluasterone CoA mostly includes findings from lab analyses of a specific batch. For each Fluasterone CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Fluasterone may be tested according to a variety of international standards, such as European Pharmacopoeia (Fluasterone EP), Fluasterone JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Fluasterone USP).
